top of page
it's where dermatology lives


press to zoom

press to zoom

press to zoom
1/2


AI-guided CRISPR study identifies potential topical psoriasis treatments
An AI-guided network analysis of genomic data (left) highlights two protein targets, including the oxytocin receptor, identified through Biohub’s CRISPR screen in primary human skin cells (right). Image by Zhao, C., Shih, M., Ahmed, S. et al. Nat Commun (2026). Researchers have combined genome-wide CRISPR screening with artificial intelligence to identify two unexpected therapeutic targets for psoriasis, opening a possible path toward topical treatments that avoid systemic im
Allan Ryan
Aug 102 min read


Comorbidities an important consideration in HS treatment
Photo by BRI72783 via Wikimedia Commons There is greater appreciation of potential comorbidities in patients with hidradenitis suppurativa (HS), both in the adult and pediatric setting, according to a special report in the June 2026 edition of The Chronicle of Skin & Allergy. Comorbidities are common in patients with HS, and some of the most challenging to manage include inflammatory bowel disease, inflammatory arthritis, polycystic ovary syndrome, metabolic syndrome, depre
Allan Ryan
Jun 292 min read


Guselkumab offers long-term safety in all skin types
All patients self-identified as non-White and nearly 69% of treated subjects had objectively measured Fitzpatrick skin types IV through VI The IL-23 inhibitor guselkumab demonstrated efficacy out to 100 weeks in the treatment of psoriasis across a spectrum of skin types, according to poster research presented at the 2026 annual meeting of the American Academy of Dermatology (AAD) in Denver. A full report will be published in the June 2026 issue of The Chronicle of Skin & Alle
Allan Ryan
Jun 83 min read


Psoriasis and the Mediterranean diet
Photo by G.steph.rocket via Wikimedia Commons Study shows positive effects of diet on normal-weight patients with psoriasis A healthy diet is widely considered to play a role in improving psoriasis symptoms, supporting the anti-inflammatory benefits of weight loss in overweight or obese psoriasis patients, but there are benefits independent of weight loss seen in patients of all body weights. That’s according to Dr. Javier Perez-Bootelloof, Hospital Universitario Ramón y Caja
Allan Ryan
Jun 13 min read
Featured Posts


bottom of page
